Assignee
ARGENX BVBA
BE·12 granted patents·2 pending applications·35 citations·filing 2013–2022
Top patents by PatentIndex Score
14 records- 0192US10316073B2FCRN antagonists and methods of useARGENX BVBA·Filed 2014·Granted Jun 11, 2019·20 cites·10 claims
- 0289US11161900B2Antibodies that specifically bind to human complement factor C2bARGENX BVBA·Filed 2019·Granted Nov 2, 2021·2 cites·12 claims
- 0387US10793627B2GARP-TGF-β 1 IGG antibodiesARGENX BVBA·Filed 2019·Granted Oct 6, 2020·2 cites·1 claims
- 0483US11072665B2Antibodies to CD70ARGENX BVBA·Filed 2015·Granted Jul 27, 2021·2 cites·39 claims
- 0582US10875914B2Nucleic acids encoding GARP-TGF-beta 1 antibodiesARGENX BVBA·Filed 2019·Granted Dec 29, 2020·1 cites·18 claims
- 0679US10696741B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Jun 30, 2020·1 cites·23 claims
- 0779US10040870B2Highly diverse combinatorial antibody librariesARGENX BVBA·Filed 2013·Granted Aug 7, 2018·5 cites·4 claims
- 0878US10479829B2GARP-TGF-beta 1 antibodiesARGENX BVBA·Filed 2018·Granted Nov 19, 2019·1 cites·16 claims
- 0975US2023088269A1Anti-il-22r antibodiesARGENX BVBA·Filed 2022·Application pending·0 cites
- 1072US11117959B2IL-6 binding moleculesARGENX BVBA·Filed 2019·Granted Sep 14, 2021·0 cites·15 claims
- 1172US10487156B2Asymmetric multispecific antibodiesARGENX BVBA·Filed 2015·Granted Nov 26, 2019·1 cites·6 claims
- 1269US11261246B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Mar 1, 2022·0 cites·23 claims
- 1367US10676535B2Anti c-Met antibodiesARGENX BVBA·Filed 2017·Granted Jun 9, 2020·0 cites·10 claims
- 1467US2021324061A1Garp-tgf-beta antibodiesARGENX BVBA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARGENX BVBA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →